The Comparison of the 50 gr Oral Glucose Tolerrance Test Results with the Body Mass Index in the Pregnancy Period of Women
Abstract
Objectives: The direct corellation between body mass index and gestational diabetes mellitus has been shown in recent studies. In this study, our aim is to compare our cases’ body mass index with the results of 50 grams OGTT who have 24-28 weeks gestation and to evaluate the OGTT results of the groups which are categorized as weak, normal weight, overweight, obese and morbidly obese according to body mass index.
Materials and Methods: There were included 200 patients who referred to our hospital as having a 24-28 weeks gestation. Our patients’ height and weight measuements were performed. By calculating body mass index, they were grouped as weak, normal weight, overweight, obese and morbidly obese 50 grams of glucose were applied orally at any time of the day without considering patient’s hunger.Body mass index and OGTT results were examined by comparing.
Results: In the group of patients who had lower body mass index value than 25 kg/m2 , it was seen that the rate of patients who have lower OGTT value than 140 mg/dl was statistically much more than others. Between the group of patients who have lower OGTT value than 140 mg/dl and the group of patients who have 140 mg/dl and higher, the rate of patients who have body mass index value between 25 and 25.9 was found statistically similar. Considering the group which had lower OGTT value than 140 mg/dl, the rate of patients who have 30 kg/ m2 and higher body mass index level was statistically higher in the group which has 140 mg/dl and higher.
Conclusion: Obesity is a serious risk factor for gestational diabetes mellitus. Pregnant women who have 30 kg/ m2 and higher body mass index value should be tested for diabets at the first antepartum visit and if there is not encountered any pathological situation 50 grams OGTT should be repeated in 24-28 weeks gestation.
Keywords
body mass index,oral glucose tolerance test 50 gr,gestational dibetes mellitus
Kaynakça
- 1. Nedim Çiçek M, Akyurek C, Çelik C, Haberal A. Diabetes mellitus ve gebelik. Kadın Hastalıkları ve Dogum Bilgisi 2006: 435-450.
- 2. Carpenter MW, Coustan DR. Criteria for scree-ning tests for gestational diabetes mellitus. Am Obstet Gynecol 1982;144(7):768.
- 3. Turok DK, Ratcliffe SD, Baxley AG.Management of gestational diabetes mellittus. Am Fam Physician 2003;68(9):1769-1772.
- 4. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, To-losa JE, Anderson GB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361:1339 –1348
- 5. Özçimen EE, Uçkuyu A, Çiftçi FC, Yanık FF, Bakar C. Diagnosis of gestational diabetes mellitus by use of the homeostasis model assessment insulin resistance index in the first trimester.GynecolEndocrinol2008:24(4):224-249. http://dx.doi.org/10.1080/09513590801948416 PMid:18382910
- 6. Marquette GP, Klein VR, Niebyl JR. Efficacy of screening for gestational diabetes. Am J Perinatol 1985:2(1):7-9. http://dx.doi.org/10.1055/s-2007-999901 PMid:3921038
- 7. O\’Sullivan JB, Mahan CM, Charles D, Dandrow RV. Screening criteria for high risk gestational diabetic patients. Am J Obstet Gynecol 1973;116(9):895-900. PMid:4718216
- 8. Hills S. DIAMAP – mapping the future of diabetes research. Diabetes Voice. 2009;54(3):45–8.
- 9. Halban PA. Prime time for DIAMAP: A road map for diabetes research in Europe. Diabetologia. 2010;53(9):1835–7. doi: 10.1007/s00125-010-1774-0.
- 10. Kuhl C. Glucose metabolism during and after pregnancy in normal and gestational diabetic woman. Acta Endocrinol 1995;79(4):709-719